IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions

References

• Dorhoi A, Reece ST, Kaufmann SHE. For better or for worse: the immune response against Mycobacterium tuberculosis balances pathology and protection. Immunol. Rev.240(1), 235–251 (2011).
   PubMed Web of Science ®Google Scholar
• Lawn SD, Zumla AI. Tuberculosis. Lancet378(9785), 57–72 (2011).
   PubMed Web of Science ®Google Scholar
• Kaufmann SHE. Fact and fiction in tuberculosis vaccine research: 10 years later. Lancet Infect. Dis.11(8), 633–640 (2011).
   PubMed Web of Science ®Google Scholar
• Grant AD, Charalambous S, Fielding KL et al. Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: a novel randomized incremental recruitment study. JAMA293(22), 2719–2725 (2005).
   PubMed Web of Science ®Google Scholar
• Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lancet356(9235), 1099–1104 (2000).
   PubMed Web of Science ®Google Scholar
• Lalvani A, Pareek M. A 100 year update on diagnosis of tuberculosis infection. Br. Med. Bull.93, 69–84 (2010).
   PubMed Web of Science ®Google Scholar
• Mandalakas AM, Detjen AK, Hesseling AC, Benedetti A, Menzies D. Interferon-γ release assays and childhood tuberculosis: systematic review and meta-analysis. Int. J. Tuberc. Lung Dis.15(8), 1018–1032 (2011).
   PubMed Web of Science ®Google Scholar
• Sester M, Sotgiu G, Lange C et al. Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur. Respir. J.37, 100–111 (2011).
   PubMed Web of Science ®Google Scholar
• Diel R, Goletti D, Ferrara G et al. Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur. Respir. J.37(1), 88–99 (2011).
   PubMed Web of Science ®Google Scholar
• Kabeer BSA, Sikhamani R, Raja A. Comparison of interferon γ-inducible protein-10 and interferon γ-based QuantiFERON TB Gold assays with tuberculin skin test in HIV-infected subjects. Diagn. Microbiol. Infect. Dis.71(3), 236–243 (2011).
   PubMed Web of Science ®Google Scholar
• Cattamanchi A, Smith R, Steingart KR et al. Interferon-γ release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis. J. Acquired Immune Defic. Syndromes56(3), 230–238 (2011).
   PubMed Web of Science ®Google Scholar
• Bélard E, Semb S, Ruhwald M et al. Prednisolone treatment affects the performance of the QuantiFERON gold in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis infection. Inflamm. Bowel Dis.17(11), 2340–2349 (2011).
   PubMed Web of Science ®Google Scholar
• Aabye MG, Ravn P, PrayGod G et al. The impact of HIV infection and CD4 cell count on the performance of an interferon γ release assay in patients with pulmonary tuberculosis. PLoS One4(1), e4220 (2009).
   Google Scholar
• Aichelburg MC, Rieger A, Breitenecker F et al. Detection and prediction of active tuberculosis disease by a whole-blood interferon-γ release assay in HIV-1-infected individuals. Clin. Infect. Dis.48(7), 954–962 (2009).
   PubMed Web of Science ®Google Scholar
• Søborg B, Andersen AB, Melbye M et al. Risk factors for Mycobacterium tuberculosis infection among children in Greenland. Bull. WHO89(10), 741E–748E (2011).
   PubMed Web of Science ®Google Scholar
• Lange C, Rieder HL. Intention to test is intention to treat. Am. J. Respir. Crit. Care Med.183(1), 3–4 (2011).
   PubMedGoogle Scholar
• Ruhwald M, Bjerregaard-Andersen M, Rabna P, Kofoed K, Eugen-Olsen J, Ravn P. IP-10/CXCL10 release is induced by incubation of whole blood from tuberculosis patients with ESAT-6, CFP10 and TB7.7. Microbes Infect.9(7), 806–812 (2007).
   PubMed Web of Science ®Google Scholar
• Bibova I, Linhartova I, Stanek O et al. Detection of immune cell response to M. tuberculosis-specific antigens by quantitative polymerase chain reaction. Diagn. Microbiol. Infect. Dis.72(1), 68–72 (2012).
   PubMedGoogle Scholar
• Chegou N, Black G, Kidd M, van Helden P, Walzl G. Host markers in QuantiFERON supernatants differentiate active TB from latent TB infection: preliminary report. BMC Pulmonary Med.9(1), 21 (2009).
   PubMedGoogle Scholar
• Frahm M, Goswami ND, Owzar K et al. Discriminating between latent and active tuberculosis with multiple biomarker responses. Tuberculosis91(3), 250–256 (2011).
   PubMed Web of Science ®Google Scholar
• Hasan Z, Rao N, Salahuddin N et al.M. tuberculosis sonicate induced IFNγ, CXCL10 and IL10 can differentiate severity in tuberculosis. Scand. J. Immunol. doi:10.1111/j.1365-3083.2011.02642.x (2011) (Epub ahead of print).
   Google Scholar
• Ruhwald M, Bjerregaard-Andersen M, Rabna P, Eugen-Olsen J, Ravn P. IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay. BMC Res. Notes2(1), 19 (2009).
   PubMedGoogle Scholar
• Sutherland JS, de Jong BC, Jeffries DJ, Adetifa IM, Ota MOC. Production of TNF-α, IL-12(p40) and IL-17 can discriminate between active TB disease and latent infection in a West African cohort. PLoS One5(8), e12365 (2010).
   PubMed Web of Science ®Google Scholar
• Kellar KL, Gehrke J, Weis SE et al. Multiple cytokines are released when blood from patients with tuberculosis is stimulated with mycobacterium tuberculosis antigens. PLoS One6(11), e26545 (2011).
   Google Scholar
• Lighter-Fisher J, Peng CH, Tse DB. Cytokine responses to QuantiFERON® peptides, purified protein derivative and recombinant ESAT-6 in children with tuberculosis. Int. J. Tuberc. Lung Dis.14(12), 1548–1555 (2010).
   PubMed Web of Science ®Google Scholar
• Nemeth J, Winkler HM, Boeck L et al. Specific cytokine patterns of pulmonary tuberculosis in Central Africa. Clin. Immunol.138(1), 50–59 (2011).
   PubMedGoogle Scholar
• Li L, Qiao D, Fu X, Lao S, Zhang X, Wu C. Identification of Mycobacterium tuberculosis-specific Th1, Th17 and Th22 cells using the expression of CD40L in tuberculous pleurisy. PLoS One6(5), e20165 (2011).
   Google Scholar
• Chegou NN, Hoek KGP, Kriel M, Warren RM, Victor TC, Walzl G. Tuberculosis assays: past, present and future. Expert Rev. Anti Infect. Ther.9(4), 457–469 (2011).
   PubMed Web of Science ®Google Scholar
• Lalvani A, Millington KA. T-cell interferon-γ release assays: can we do better? Eur. Respir. J.32(6), 1428–1430 (2008).
   PubMedGoogle Scholar
• Lalvani A, Pareek M. Interferon γ release assays: principles and practice. Enferm. Infecc. Microbiol. Clin.28(4), 245–252 (2010).
   PubMed Web of Science ®Google Scholar
• Lange C, Mori T. Advances in the diagnosis of tuberculosis. Respirology15(2), 220–240 (2010).
   PubMedGoogle Scholar
• Walzl G, Ronacher K, Hanekom W, Scriba TJ, Zumla A. Immunological biomarkers of tuberculosis. Nat. Rev. Immunol.11(5), 343–354 (2011).
   PubMed Web of Science ®Google Scholar
• van der Werf MJ, van Leth F. Latent tuberculosis infection and interferon-γ release assays: what new knowledge did we gain through the Journal in 2009? Int. J. Tuberc. Lung Dis.14(12), 1525–1529 (2010).
   PubMedGoogle Scholar
• Kasprowicz VO, Churchyard G, Lawn SD, Squire SB, Lalvani A. Diagnosing latent tuberculosis in high-risk individuals: rising to the challenge in high-burden areas. J. Infect. Dis.204(Suppl. 4), S1168–S1178 (2011).
   PubMed Web of Science ®Google Scholar
• Dhillon NK, Peng F, Ransohoff RM, Buch S. PDGF Synergistically enhances IFN-γ-induced expression of CXCL10 in blood-derived macrophages: implications for HIV dementia. J. Immunol.179(5), 2722–2730 (2007).
   PubMedGoogle Scholar
• Moser B, Loetscher P. Lymphocyte traffic control by chemokines. Nat. Immunol.2(2), 123–128 (2001).
   PubMed Web of Science ®Google Scholar
• Groom JR, Luster AD. CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol. Cell Biol.89(2), 207–205 (2011).
   PubMed Web of Science ®Google Scholar
• Farber JM. Mig and IP-10: CXC chemokines that target lymphocytes. J. Leukoc. Biol.61(3), 246–257 (1997).
   PubMed Web of Science ®Google Scholar
• Narumi S, Finke JH, Hamilton TA. Interferon γ and interleukin 2 synergize to induce selective monokine expression in murine peritoneal macrophages. J. Biol. Chem.265(12), 7036–7041 (1990).
   PubMed Web of Science ®Google Scholar
• Sauty A, Dziejman M, Taha RA et al. The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells. J. Immunol.162(6), 3549–3558 (1999).
   PubMed Web of Science ®Google Scholar
• Karonitsch T, Dalwigk K, Steiner CW et al. Interferon (IFN) signals and monocytic sensitization of the IFNγ signaling pathway in peripheral blood of rheumatoid arthritis patients. Arthritis Rheum. doi:10.1002/art.33347 (2011) (Epub ahead of print).
   Google Scholar
• Ohmori Y, Wyner L, Narumi S, Armstrong D, Stoler M, Hamilton TA. Tumor necrosis factor-α induces cell type and tissue-specific expression of chemoattractant cytokines in vivo. Am. J. Pathol.142(3), 861–870 (1993).
   PubMed Web of Science ®Google Scholar
• Guzzo C, Che Mat NF, Gee K. Interleukin-27 induces a STAT1/3- and NF-κB-dependent proinflammatory cytokine profile in human monocytes. J. Biol. Chem.285(32), 24404–24411 (2010).
   PubMed Web of Science ®Google Scholar
• Rudner XL, Happel KI, Young EA, Shellito JE. Interleukin-23 (IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection. Infect. Immun.75(6), 3055–3061 (2007).
   PubMed Web of Science ®Google Scholar
• Khader SA, Bell GK, Pearl JE et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol.8(4), 369–377 (2007).
   PubMed Web of Science ®Google Scholar
• Qian C, An H, Yu Y, Liu S, Cao X. TLR agonists induce regulatory dendritic cells to recruit Th1 cells via preferential IP-10 secretion and inhibit Th1 proliferation. Blood109(8), 3308–3315 (2007).
   PubMedGoogle Scholar
• Chen J, Liu X. The role of interferon γ in regulation of CD4+ T-cells and its clinical implications. Cell Immunol.254(2), 85–90 (2009).
   PubMed Web of Science ®Google Scholar
• Farrar MA, Schreiber RD. The molecular cell biology of interferon-γ and its receptor. Annu. Rev. Immunol.11, 571–611 (1993).
   PubMed Web of Science ®Google Scholar
• Aabye MG, Ravn P, Johansen IS, Eugen-Olsen J, Ruhwald M. Incubation of whole blood at 39°C augments IP-10 and IFN-γ responses to M. tuberculosis antigens. Clin. Vaccine Immunol.18(7), 1150–1156 (2011).
   PubMedGoogle Scholar
• Goletti D, Raja A, Kabeer BSA et al. IFN-[γ], but not IP-10, MCP-2 or IL-2 response to RD1 selected peptides associates to active tuberculosis. J. Infect.61(2), 133–143 (2010).
   PubMed Web of Science ®Google Scholar
• Kabeer BSA, Raja A, Raman B et al. IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapy. BMC Infect. Dis.11, 135 (2011).
   PubMedGoogle Scholar
• Ruhwald M, Bodmer T, Maier C et al. Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis. Eur. Respir. J.32(6), 1607–1615 (2008).
   PubMed Web of Science ®Google Scholar
• Ruhwald M, Dominguez J, Latorre I et al. A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis. Tuberculosis91(3), 260–267 (2011).
   PubMed Web of Science ®Google Scholar
• Kabeer BSA, Raman B, Thomas A, Perumal V, Raja A. Role of QuantiFERON-TB gold, interferon γ inducible protein-10 and tuberculin skin test in active tuberculosis diagnosis. PLoS One5(2), e9051 (2010).
   Google Scholar
• Aabye MG, Ruhwald M, Praygod G et al. Potential of interferon-{γ}-inducible protein 10 in improving tuberculosis diagnosis in HIV-infected patients. Eur. Respir. J.36(6), 1488–1490 (2010).
   PubMed Web of Science ®Google Scholar
• Goletti D, Raja A, Kabeer BSA et al. Is IP-10 an accurate marker for detecting M. tuberculosis-specific response in HIV-infected persons? PLoS One5(9), e12577 (2010).
   PubMedGoogle Scholar
• Chintu C, Mudenda V, Lucas S et al. Lung diseases at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study. Lancet360(9338), 985–990 (2002).
   PubMed Web of Science ®Google Scholar
• McNally LM, Jeena PM, Gajee K et al. Effect of age, polymicrobial disease, and maternal HIV status on treatment response and cause of severe pneumonia in South African children: a prospective descriptive study. Lancet369(9571), 1440–1451 (2007).
   PubMed Web of Science ®Google Scholar
• Marais BJ, Gie RP, Schaaf HS, Beyers N, Donald PR, Starke JR. Childhood pulmonary tuberculosis: old wisdom and new challenges. Am. J. Respir. Crit. Care Med.173(10), 1078–1090 (2006).
   PubMed Web of Science ®Google Scholar
• Marais BJ, Pai M. New approaches and emerging technologies in the diagnosis of childhood tuberculosis. Paediatr. Respir. Rev.8(2), 124–133 (2007).
   PubMed Web of Science ®Google Scholar
• Yassin MA, Petrucci R, Garie KT et al. Can interferon-γ or interferon-γ-induced-protein-10 differentiate tuberculosis infection and disease in children of high endemic areas? PLoS One6(9), e23733 (2011).
   Web of Science ®Google Scholar
• Alsleben N, Ruhwald M, Rüssmann H, Marx FM, Wahn U, Magdorf K. Interferon-γ inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case–control study. Scand. J. Infect. Dis. doi:10.3109/00365548.2011.632644 (2011).
   PubMedGoogle Scholar
• Lighter J, Rigaud M, Huie M, Peng CH, Pollack H. Chemokine IP-10: an adjunct marker for latent tuberculosis infection in children. Int. J. Tuberc. Lung Dis.13(6), 731–736 (2009).
   PubMedGoogle Scholar
• Ruhwald M, Petersen J, Kofoed K et al. Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10. PLoS One3(8), e2858 (2008).
   PubMed Web of Science ®Google Scholar
• Machingaidze S, Wiysonge CS, Gonzalez-Angulo Y et al. The utility of an interferon γ release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis. Pediatr. Infect. Dis. J.30(8), 694–700 (2011).
   PubMed Web of Science ®Google Scholar
• Akolo C, Adetifa I, Shepperd S, Volmink J. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst. Rev.1, CD000171 (2010).
   PubMed Web of Science ®Google Scholar
• Santin M, Casas S, Saumoy M et al. Detection of latent tuberculosis by the tuberculin skin test and a whole-blood interferon-γ release assay, and the development of active tuberculosis in HIV-seropositive persons. Diagn. Microbiol. Infect. Dis.69(1), 59–65 (2011).
   PubMed Web of Science ®Google Scholar
• Latorre I, Martínez-Lacasa X, Font R et al. IFN-γ response on T-cell based assays in HIV-infected patients for detection of tuberculosis infection. BMC Infect. Dis.10, 348 (2010).
   PubMedGoogle Scholar
• Leidl L, Mayanja-Kizza H, Sotgiu G et al. Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection. Eur. Respir. J.35(3), 619–626 (2010).
   PubMedGoogle Scholar
• Kabeer BSA, Sikhamani R, Swaminathan S, Perumal V, Paramasivam P, Raja A. Role of interferon γ release assay in active TB diagnosis among HIV infected individuals. PLoS One4(5), e5718 (2009).
   Google Scholar
• Raby E, Moyo M, Devendra A et al. The effects of HIV on the sensitivity of a whole blood IFN-γ release assay in Zambian adults with active tuberculosis. PLoS One3(6), e2489 (2008).
   PubMedGoogle Scholar
• Brock I, Ruhwald M, Lundgren B, Westh H, Mathiesen LR, Ravn P. Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-γ test. Respir. Res.7, 56 (2006).
   PubMed Web of Science ®Google Scholar
• Kabeer BS, Sikhamani R, Raja A. Comparison of interferon γ and interferon γ-inducible protein-10 secretion in HIV-tuberculosis patients. AIDS24(2), 323–325 (2010).
   PubMedGoogle Scholar
• Sutherland JS, Young JM, Peterson KL et al. Polyfunctional CD4+ and CD8+ T cell responses to tuberculosis antigens in HIV-1-infected patients before and after anti-retroviral treatment. J. Immunol.184(11), 6537–6544 (2010).
   PubMedGoogle Scholar
• Qi XF, Kim DH, Yoon YS et al. Essential involvement of cross-talk between IFN-γ and TNF-α in CXCL10 production in human THP-1 monocytes. J. Cell. Physiol.220(3), 690–697 (2009).
   PubMed Web of Science ®Google Scholar
• Solovic I, Sester M, Gomez-Reino JJ et al. The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement. Eur. Respir. J.36(5), 1185–1206 (2010).
   PubMed Web of Science ®Google Scholar
• Bélard E, Semb S, Ruhwald M et al. Prednisolone treatment affects the performance of the QuantiFERON gold in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis infection. Inflamm. Bowel Dis.17(11), 2340–2349 (2011).
   PubMed Web of Science ®Google Scholar
• Chen DY, Shen GH, Chen YM et al. Interferon-inducible protein-10 as a marker to detect latent and active tuberculosis in rheumatoid arthritis. Int. J. Tuberc. Lung Dis.15(2), 192–200 (2011).
   PubMedGoogle Scholar
• Lei HY, Chang CP. Lectin of concanavalin A as an anti-hepatoma therapeutic agent. J. Biomed. Sci.16, 10 (2009).
   PubMedGoogle Scholar
• Itoh Y, Morita A, Nishioji K et al. Time course profile and cell-type-specific production of monokine induced by interferon-γ in concanavalin A-induced hepatic injury in mice: comparative study with interferon-inducible protein-10. Scand. J. Gastroenterol.36(12), 1344–1351 (2001).
   PubMedGoogle Scholar
• Denkinger CM, Dheda K, Pai M. Guidelines on interferon-γ release assays for tuberculosis infection: concordance, discordance or confusion? Clin. Microbiol. Infect.17(6), 806–814 (2011).
   PubMed Web of Science ®Google Scholar
• Sester M, Sotgiu G, Lange C et al. Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur. Respir. J.37(1), 100–111 (2011).
   PubMed Web of Science ®Google Scholar
• Goletti D, Carrara S, Butera O et al. Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TBNET-Study. PLoS One3(10), e3417 (2008).
   Web of Science ®Google Scholar
• Skogstrand K, Thorsen P, Nørgaard-Pedersen B, Schendel DE, Sørensen LC, Hougaard DM. Simultaneous measurement of 25 inflammatory markers and neurotrophins in neonatal dried blood spots by immunoassay with xMAP technology. Clin. Chem.51(10), 1854–1866 (2005).
   PubMed Web of Science ®Google Scholar
• Geluk A, van der Ploeg-van Schip JJ, van Meijgaarden KE et al. Enhancing sensitivity of detection of immune responses to Mycobacterium leprae peptides in whole-blood assays. Clin. Vaccine Immunol.17(6), 993–1004 (2010).
   PubMedGoogle Scholar
• Chen J, Wang S, Zhang Y et al. Rv1985c, a promising novel antigen for diagnosis of tuberculosis infection from BCG-vaccinated controls. BMC Infect. Dis.10, 273 (2010).
   PubMed Web of Science ®Google Scholar
• Millington KA, Fortune SM, Low J et al. Rv3615c is a highly immunodominant RD1 (region of difference 1)-dependent secreted antigen specific for Mycobacterium tuberculosis infection. Proc. Natl Acad. Sci. USA108(14), 5730–5735 (2011).
   PubMed Web of Science ®Google Scholar
• Bertholet S, Horne DJ, Laughlin EM et al. Effect of chemotherapy on whole blood cytokine profiles to Mycobacterium tuberculosis antigens in a small cohort of pulmonary tuberculosis patients. Clin. Vaccine Immunol.18(8), 1378–1386 (2011).
   PubMedGoogle Scholar
• Goletti D, Butera O, Vanini V et al. Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection. Eur. Respir. J.36(1), 135–142 (2010).
   PubMed Web of Science ®Google Scholar
• Schuck SD, Mueller H, Kunitz F et al. Identification of T-cell antigens specific for latent Mycobacterium tuberculosis infection. PLoS One4(5), e5590 (2009).
   PubMed Web of Science ®Google Scholar
• Chiacchio T, Petruccioli E, Vanini V et al. Higher frequency of T-cell response to M. tuberculosis latency antigen Rv2628 at the site of active tuberculosis disease than in peripheral blood. PLoS One6(11), e27539 (2011).
   PubMed Web of Science ®Google Scholar
• Butera O, Chiacchio T, Carrara S et al. New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response. BMC Infect. Dis.9, 182 (2009).
   PubMed Web of Science ®Google Scholar
• Leyten EM, Lin MY, Franken KL et al. Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis. Microbes Infect.8(8), 2052–2060 (2006).
   PubMed Web of Science ®Google Scholar
• Denis M, Wedlock DN, McCarthy AR et al. Enhancement of the sensitivity of the whole-blood γ interferon assay for diagnosis of Mycobacterium bovis infections in cattle. Clin. Vaccine Immunol.14(11), 1483–1489 (2007).
   PubMedGoogle Scholar
• Feske ML, Medina M, Graviss EA, Lewis DE. IL-7 addition increases spot size and number as measured by T-SPOT.TB(®). Methods Mol. Biol.792, 229–241 (2012).
   PubMedGoogle Scholar
• Feske M, Nudelman RJ, Medina M et al. Enhancement of human antigen-specific memory T-cell responses by interleukin-7 may improve accuracy in diagnosing tuberculosis. Clin. Vaccine Immunol.15(10), 1616–1622 (2008).
   PubMedGoogle Scholar
• Mei JV, Zobel SD, Hall EM, De Jesús VR, Adam BW, Hannon WH. Performance properties of filter paper devices for whole blood collection. Bioanalysis2(8), 1397–1403 (2010).
   PubMedGoogle Scholar
• Kasprowicz VO, Mitchell JE, Chetty S et al. A molecular assay for sensitive detection of pathogen-specific T-cells. PLoS One6(8), e20606 (2011).
   PubMedGoogle Scholar
• Chakera A, Bennett SC, Cornall RJ. A whole blood monokine-based reporter assay provides a sensitive and robust measurement of the antigen-specific T cell response. J. Translat. Med.9(1), 143 (2011).
   PubMedGoogle Scholar
• Lange B, Vavra M, Kern M, Wagner D. IP-10 measurement using a point of care test for the diagnosis of active tuberculosis. Presented at: The European Respiratory Society Annual Congress. Amsterdam, The Netherlands, 24–28 September 2011 (Abstract #1900).
   Google Scholar
• Su WL, Perng WC, Huang CH, Yang CY, Wu CP, Chen JH. Association of reduced tumor necrosis factor α, γ interferon, and interleukin-1β (IL-1β) but increased IL-10 expression with improved chest radiography in patients with pulmonary tuberculosis. Clin. Vaccine Immunol.17(2), 223–231 (2010).
   PubMedGoogle Scholar
• Lu C, Wu J, Wang H et al. Novel biomarkers distinguishing active tuberculosis from latent infection identified by gene expression profile of peripheral blood mononuclear cells. PLoS One6(8), e24290 (2011).
   Google Scholar
• Berry MPR, Graham CM, McNab FW et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature466(7309), 973–977 (2010).
   PubMed Web of Science ®Google Scholar
• Azzurri A, Sow OY, Amedei A et al. IFN-γ-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection. Microbes Infect.7(1), 1–8 (2005).
   PubMed Web of Science ®Google Scholar
• Casrouge A, Decalf J, Ahloulay M et al. Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV. J. Clin. Invest.121(1), 308–317 (2011).
   PubMedGoogle Scholar
• Zeremski M, Hooker G, Shu MA et al. Induction of CXCR3- and CCR5-associated chemokines during acute hepatitis C virus infection. J. Hepatol.55(3), 545–553 (2011).
   PubMedGoogle Scholar
• Askarieh G, Alsiö A, Pugnale P et al. Systemic and intrahepatic interferon-γ-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C. Hepatology51(5), 1523–1530 (2010).
   PubMed Web of Science ®Google Scholar
• Ng PC, Li K, Chui KM et al. IP-10 is an early diagnostic marker for identification of late-onset bacterial infection in preterm infants. Pediatr. Res.61(1), 93–98 (2007).
   PubMed Web of Science ®Google Scholar
• Punyadeera C, Schneider EM, Schaffer D et al. A biomarker panel to discriminate between systemic inflammatory response syndrome and sepsis and sepsis severity. J. Emerg. Trauma Shock3(1), 26–35 (2010).
   PubMedGoogle Scholar
• Olszyna DP, Prins JM, Dekkers PE et al. Sequential measurements of chemokines in urosepsis and experimental endotoxemia. J. Clin. Immunol.19(6), 399–405 (1999).
   PubMed Web of Science ®Google Scholar
• Zeremski M, Petrovic LM, Talal AH. The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection. J. Viral Hepat.14(10), 675–687 (2007).
   PubMed Web of Science ®Google Scholar
• Ng PC, Lam CWK, Li AM et al. Chemokine response in children with SARS. Arch. Dis. Child90(4), 422–423 (2005).
   PubMedGoogle Scholar
• Bai X, Wilson SE, Chmura K, Feldman NE, Chan ED. Morphometric analysis of Th(1) and Th(2) cytokine expression in human pulmonary tuberculosis. Tuberculosis84(6), 375–385 (2004).
   PubMed Web of Science ®Google Scholar
• Pokkali S, Das SD, R L. Expression of CXC and CC type of chemokines and its receptors in tuberculous and non-tuberculous effusions. Cytokine41(3), 307–314 (2008).
   PubMedGoogle Scholar
• Dheda K, Van-Zyl Smit RN, Sechi LA et al. Clinical diagnostic utility of IP-10 and LAM antigen levels for the diagnosis of tuberculous pleural effusions in a high burden setting. PLoS One4(3), e4689 (2009).
   Web of Science ®Google Scholar
• Cannas A, Calvo L, Chiacchio T et al. IP-10 detection in urine is associated with lung diseases. BMC Infect. Dis.10, 333 (2010).
   PubMed Web of Science ®Google Scholar
• Hang NTL, Lien LT, Kobayashi N et al. Analysis of factors lowering sensitivity of interferon-γ release assay for tuberculosis. PLoS One6(8), e23806 (2011).
   Google Scholar
• Li L, Qiao D, Zhang X, Liu Z, Wu C. The immune responses of central and effector memory BCG-specific CD4+ T cells in BCG-vaccinated PPD+ donors were modulated by Treg cells. Immunobiology216(4), 477–484 (2011).
   PubMedGoogle Scholar
• Rueda CM, Marín ND, García LF, Rojas M. Characterization of CD4 and CD8 T cells producing IFN-γ in human latent and active tuberculosis. Tuberculosis90(6), 346–353 (2010).
   PubMedGoogle Scholar
• Petrucci R, Abu AN, Gurgel RQ et al. Interferon γ, interferon-γ-induced-protein 10, and tuberculin responses of children at high risk of tuberculosis infection. Pediatr. Infect. Dis. J.27(12), 1073–1077 (2008).
   PubMedGoogle Scholar
• Whittaker E, Gordon A, Kampmann B. Is IP-10 a better biomarker for active and latent tuberculosis in children than IFNγ? PLoS One3(12), e3901 (2008).
   PubMed Web of Science ®Google Scholar